Susquehanna International Group
LUNG icon

Susquehanna International Group’s Pulmonx LUNG Stock Holding History

Susquehanna International Group’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$106K Sell
82,200
-8,600
-9% -$14.2K ﹤0.01% 12307
2025
Q4 		$201K Buy
+90,800
New +$171K ﹤0.01% 10873
2025
Q2 		– Sell
-10,600
Closed -$71.3K – 13275
2025
Q1 		$71.3K Sell
10,600
-300
-3% -$2.12K ﹤0.01% 11733
2024
Q4 		$74K Buy
10,900
+100
+0.9% +$658 ﹤0.01% 11513
2024
Q3 		$89.5K Buy
+10,800
New +$78.1K ﹤0.01% 11115
2023
Q1 		– Sell
-36,000
Closed -$303K – 13108
2022
Q4 		$303K Buy
36,000
+26,000
+260% +$247K ﹤0.01% 9068
2022
Q3 		$167K Buy
+10,000
New +$184K ﹤0.01% 11098
2022
Q2 		– Sell
-194,000
Closed -$4.81M – 13512
2022
Q1 		$4.81M Buy
+194,000
New +$5.01M ﹤0.01% 3697

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Susquehanna International Group's LUNG Position: Q1 2026 in Review

Susquehanna International Group reduced its Pulmonx (LUNG) stake by 53% in Q1 2026, selling an estimated $166K and leaving 89,069 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #12240.

Susquehanna International Group first reported a position in LUNG in Q1 2022 and has held it in 17 quarters since. The position peaked at $4.51M in Q1 2022. 114 funds tracked by Wall St. Rank hold LUNG as of Q1 2026.

  • Susquehanna International Group held 89,069 shares of Pulmonx worth $115K as of Q1 2026.
  • Susquehanna International Group sold 100,371 Pulmonx shares in Q1 2026, an estimated $166K.
  • Pulmonx made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12240 holding.
  • Susquehanna International Group first reported a position in Pulmonx in Q1 2022 and has held it in 17 quarters since.
  • Susquehanna International Group's Pulmonx position peaked at $4.51M in Q1 2022.
  • 114 funds tracked by Wall St. Rank held Pulmonx as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.